Last updated: January 17, 2024
Sponsor: Medical University of Graz
Overall Status: Completed
Phase
4
Condition
Thrombosis
Blood Clots
Platelet Disorders
Treatment
Tramadol
Clinical Study ID
NCT05237492
1
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18y and older, healthy volunteers
Exclusion
Exclusion Criteria:
- Age < 18 years
- Pregnant women
- History of addiction (especially opiate abuse)
- Pre-existing general addictive disease
- Ongoing pain therapy with opiates
- Taking antidepressants (SNRI, SSRI)
- History of thrombocytopathy or coagulation disorders
- Therapy with drugs that influence thrombocyte function (ASS, clopidogrel, prasugrel,ticagrelor or similar)
- Known intolerance to opiates
Study Design
Total Participants: 33
Treatment Group(s): 1
Primary Treatment: Tramadol
Phase: 4
Study Start date:
January 26, 2022
Estimated Completion Date:
July 15, 2023
Study Description
Connect with a study center
Dept. of Anaesthesiology and Intensive Care Medicine, Medical University of Graz
Graz, 8010
AustriaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.